Why the study?
Cardio-metabolic disease causes significant mortality and morbidity, and the study aimed to evaluate the function of Omega-3 and Omega-6 single-chain lipid acids in enhancing cardio-metabolic health.
Do Omega-3 and Omega-6 polyunsaturated fatty acids prevent cardio-metabolic complications?
Do Omega-3 and Omega-6 polyunsaturated fatty acids prevent cardio-metabolic complications?
Dietary intake of Omega-3 and Omega-6 PUFAs may help prevent cardio-metabolic complications by reducing inflammation and thrombogenesis.
Background: Cardio-metabolic disease is one of the deadliest diseases responsible for the current mortality and morbidity cases. Smoking, drinking alcohol, poor diet, sedentary activities, and malnutrition are some of the modifiable behaviors attributed to the cardio-metabolic disease. Improving dietary operations helps in the eradication of cardio-metabolic complications because the consumption of a balanced diet improves the pleiotropic functioning of cells. It also regulates the inflammatory as well as properties that are against inflammatory acids in the cardiovascular protection process. The purpose of this research is to study the function of Omega-3 and Omega-6 single-chain lipids acids in enhancing cardio-metabolic health. Methodology: Researchers visited several medical databases required in the acquisition of relevant information and analysis to evaluate the functional importance and effectiveness of Omega-3 and Omega-6 single-chain lipids in the prevention of cardio-metabolic complexions. Results: The findings of the research, as mentioned above process, showed that Omega-3 and Omega-6 acids keep the cells off from contracting cardio-metabolic complications. They perform this operation by lowering the inflammatory index of arteries, reducing blood clotting, and decreasing the level of low-density lipoproteins in the body. Conclusion: Polyunsaturated fatty acids (PUFAs) protect the body from cardio-metabolic risk. The human diet should have the right constituent of PUFAs to increase the concentration of single-chain lipids required to protect cardio-metabolic disease in the body.
No takes yet. Share an insight, caveat, or question.
Halim et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: